Integrating renal transporter biomarkers into drug development: Discovery, clinical assessment, and precision medicine.
Saved in:
| Title: | Integrating renal transporter biomarkers into drug development: Discovery, clinical assessment, and precision medicine. |
|---|---|
| Authors: | Yee SW; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Research and Development, Pfizer Inc., Groton, CT, USA. Electronic address: Sookwah.Yee@pfizer.com., Prasad B; Division of Translational and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA., Kusuhara H; Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan., Kimoto E; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Research and Development, Pfizer Inc., Groton, CT, USA. Electronic address: Emi.Kimoto@pfizer.com. |
| Source: | Drug metabolism and pharmacokinetics [Drug Metab Pharmacokinet] 2026 Apr; Vol. 67, pp. 101515. Date of Electronic Publication: 2026 Jan 09. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 101164773 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-0920 (Electronic) Linking ISSN: 13474367 NLM ISO Abbreviation: Drug Metab Pharmacokinet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
